RBC Capital Reiterates Outperform on Exelixis, Maintains $27 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has reiterated an Outperform rating on Exelixis (NASDAQ:EXEL) and maintained a price target of $27.
September 26, 2024 | 2:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its Outperform rating for Exelixis, maintaining a price target of $27, indicating confidence in the company's future performance.
The reiteration of an Outperform rating and maintenance of a $27 price target by RBC Capital suggests a positive outlook for Exelixis. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100